Greater Centralization, Clarity Needed in Formulating Medical Innovation Policy: Dr Teshirogi of JPMA

Speaking at a press conference held on May 17 to mark the beginning of his second term as president of the Japan Pharmaceutical Manufacturers Association (JPMA), Isao Teshirogi criticized the lack of clarity in the respective roles and functions of...read more